Table 4 Association [OR (95% CI)] between creatinine-corrected DEHP metabolites and the frequency of cancer; NHANES 2011–2018
From: Exposure to di-2-ethylhexyl phthalate (DEHP) increases the risk of cancer
Model 1 | Model 2 | Model 3 | |
|---|---|---|---|
∑DEHP | 569 | 569 | 569 |
Q1: < 5.1 ng/mg crt | Referent | Referent | Referent |
Q2: 5.1–5.6 ng/mg crt | 1.46 (1.17, 1.82) | 1.24 (0.99, 1.57) | 1.25 (0.99, 1.58) |
Q3: 5.7–6.1 ng/mg crt | 0.94 (0.74, 1.19) | 0.76 (0.60, 1.01) | 0.74(0.58, 1.00) |
Q4: > 6.1 ng/mg crt | 1.34 (1.07, 1.68) | 1.16 (0.91, 1.47) | 1.10 (0.86, 1.41) |
p trend | 0.384 | 0.783 | 0.493 |